Tesamorelin vs. Sermorelin

Tesamorelin and sermorelin are both GHRH analogs: each prompts your pituitary gland to release its own growth hormone. They differ in FDA status, in what each has been studied for, and in how each is offered. Rx2BFIT offers sermorelin on its own and tesamorelin as the Tesamorelin / Ipamorelin pairing, both prescribed and monitored by Dr. Patel.

A man in a white tank top stretching his hamstring on a red track

How each one works

Your brain controls growth hormone with a signal called growth hormone releasing hormone, or GHRH. It travels a short distance to the pituitary gland and tells it to release growth hormone in bursts. Sermorelin and tesamorelin are both copies of that one signal, so neither supplies growth hormone itself, and both depend on a pituitary that still works.

Sermorelin is the short version. Natural GHRH is a longer peptide, but only its first 29 amino acids are needed for full activity, and sermorelin is that fragment. It prompts a short burst of your own growth hormone that stays under the body's normal feedback control.

Tesamorelin is the long version: the same 44 amino acid sequence as human GHRH, with a small chemical group attached to one end. The drug itself clears within minutes. What lasts is the downstream effect, a rise in IGF-1, the hormone that carries out much of growth hormone's work and the one measured on your blood tests.

The practical difference at Rx2BFIT is the company tesamorelin keeps. It is on the menu as the Tesamorelin / Ipamorelin pairing, where ipamorelin adds a second trigger through a different receptor. Our sermorelin vs. ipamorelin guide covers that half.

A man asleep on his side in a dim bedroom

Side by side

The same questions, asked of both. Where the answer is identical, the two do not differ on that point. The tesamorelin column describes it as listed here, in the pairing.

CriterionSermorelinTesamorelin
Peptide classGHRH analog: a synthetic version of the first 29 amino acids of growth hormone releasing hormoneGHRH analog: the full 44 amino acid sequence of human GHRH with a small chemical group attached to one end
Where it actsThe GHRH receptor on the pituitary glandThe GHRH receptor on the pituitary gland (the ipamorelin it is paired with acts on the ghrelin receptor)
How it is givenSubcutaneous injectionSubcutaneous injection
How Rx2BFIT offers itOn its own, as a single peptideAs the Tesamorelin / Ipamorelin pairing, two peptides together
What Rx2BFIT lists it as possibly supportingEnergy, Muscle recovery, Healthy aging, Body compositionLean muscle, Recovery, Sleep quality, Visceral fat reduction
What the published studies coverA handful of small studies, roughly 10 to 90 people for up to 6 months, mostly in adults aged 55 to 76Two phase 3 trials in 806 adults with HIV and excess abdominal fat, plus smaller trials. The pairing itself has not been tested in a clinical trial.
FDA statusNot FDA-approved for any use. A former diagnostic and pediatric product, approved in 1990 and 1997, was discontinued in 2008.A branded tesamorelin is approved only for excess abdominal fat in adults with HIV-associated lipodystrophy, and that is not what is dispensed here. Ipamorelin is not FDA-approved for any use.
Side effects to know aboutMost often injection site pain and temporary facial flushing. Thyroid function is worth checking before and during treatment.Raises IGF-1 and can affect blood sugar, fluid retention, and joints. Not used in anyone with active cancer.
SourcingU.S. supplier, independent lab testing, certificate of analysis on file, no compounding pharmacyU.S. supplier, independent lab testing, certificate of analysis on file, no compounding pharmacy
Lab monitoringIGF-1 plus screening labs before starting, repeated about every six monthsIGF-1 plus screening labs before starting, repeated about every six months
Competitive sportProhibited at all times on the WADA listProhibited at all times on the WADA list

Which one is right for you

There is no universal winner, and this page does not pick one. The two have been studied for different things, in studies of very different sizes, and neither has been shown to slow aging. What separates them is where your goals sit and how much of a protocol you want.

You may lean toward sermorelin if you want a single peptide and the simplest plan, and your goals are broad: energy, recovery, and healthy aging as part of long-term wellness. Its research is thin, a few small studies in older adults, so expectations should be modest.

You may lean toward the pairing if your goals center on body composition: lean muscle, sleep quality, or abdominal fat. Tesamorelin has the larger trial base, and it is focused on visceral fat, but those trials were in adults with HIV-associated lipodystrophy, so using it for anything else is off-label. You also need to be comfortable with a protocol of two peptides instead of one.

Neither works quickly, and neither is a course you finish. In the sermorelin studies, IGF-1 rose within about 2 weeks while body composition changes took 3 to 6 months and were modest. In the tesamorelin trials, the visceral fat result was measured at 26 weeks, and the fat returned within months once treatment stopped.

Neither may suit you if you compete in a tested sport, have active or recent cancer, or are pregnant or trying to conceive. Raise any of these at the assessment.

The other peptides on the menu are on the peptide therapy page. When you are ready, request a free assessment and Dr. Patel will make the call with your history and labs in hand.

This page is general information, not medical advice. A consultation is required to determine eligibility and the most appropriate treatment plan.

Dr. Bhavesh Patel talking with a patient in the Rx2BFIT exam room

Frequently asked questions

Are tesamorelin and sermorelin the same thing?

They are close relatives, not the same drug. Both are synthetic versions of growth hormone releasing hormone (GHRH), the brain's signal to the pituitary. Sermorelin is the first 29 amino acids of that hormone, the shortest fragment with its full activity. Tesamorelin is the whole 44 amino acid sequence with a small chemical group added to one end.

Is tesamorelin or sermorelin FDA-approved?

Not for the uses on this page. Sermorelin was approved in 1990 as a diagnostic agent and in 1997 for growth hormone deficiency in children, was discontinued in 2008, and has no approved product today. A branded tesamorelin is approved for one use, reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Use in anyone else is off-label, and that branded product is not what Rx2BFIT dispenses.

How does Rx2BFIT offer tesamorelin?

On the Rx2BFIT menu, tesamorelin appears as the Tesamorelin / Ipamorelin pairing, which combines it with ipamorelin, a selective growth hormone secretagogue. Sermorelin is listed as a single peptide. Ipamorelin is not FDA-approved for any use, and the pairing itself has not been tested in a clinical trial.

Does tesamorelin or sermorelin cause weight loss?

Neither is a weight loss drug. The label for the approved tesamorelin product says it is not indicated for weight loss because its effect on body weight is neutral: in its trials visceral fat fell while weight stayed about the same. In the small sermorelin studies, body weight did not change either.

How do I choose between tesamorelin and sermorelin?

You do not have to choose alone. Start with a free assessment, in the Artesia office or by video. Dr. Patel takes your history, orders screening labs including IGF-1, and recommends one option, the other, or neither. Call (562) 650-0069 or send a request through the contact page.

A smiling woman in athletic wear on a rocky beach

Your free assessment is the first step.

Ready to look, feel, and perform better?

Medically reviewed by Dr. Bhavesh Patel, D.O.. This page is for education and is not a substitute for a personalized medical consultation. Last updated .